Tag: Inc.

Selagine Plasma to Advance Pooled Plasma Eye Drops for Moderate-to-Severe Dry Eye

Agreement with Selagine, Inc. supports the development of an investigational pooled plasma biologic platform intended to move beyond individualized compounded serum tearsCHICAGO, June 9,...

Mitsubishi Motors to Debut New Electric Vehicle in North America, Vehicle to be Named “Eclipse Sportback”

New model continues Mitsubishi's long history with battery electric vehiclesStoried Eclipse name reaches back to its North American debut in 1990New BEV will be...

EV Battery Market worth $168.95 billion by 2035| MarketsandMarkets™

DELRAY BEACH, Fla., June 9, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the EV Battery Market is projected to reach USD 168.95 billion by 2035, from USD...

U.S. GoldMining Provides Updates on the 2026 Exploration Program and District Infrastructure Catalysts at its 100% Owned Whistler Project, Alaska

ANCHORAGE, Alaska, June 9, 2026 /CNW/ - U.S. GoldMining Inc. (NASDAQ: USGO) ("U.S. GoldMining" or the "Company") is pleased to provide an update on the...

NX Group Launches “NX Ocean Fast Track” New Ocean Freight Service from Asia to North America Delivering Reliability and Speed

- Achieving Both Cost Reduction and Delivery Reliability with Lead Times Up to 40% Shorter than Conventional Services -TOKYO, June 9, 2026 /PRNewswire/ --...

Defiance Launches MUZ: The First 2X Short ETF for Micron Technology, Inc.

Baidu Responds to Inclusion on U.S. CMC List

BEIJING, June 9, 2026 /PRNewswire/ -- Baidu, Inc. (NASDAQ: BIDU and HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)), ("Baidu" or the "Company"), a...

Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against Via Transportation, Inc.

MILWAUKEE, June 08, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating possible securities fraud claims against Via Transportation (NYSE: VIA). The investigation results from inaccurate statements Via Transportation may have made regarding its financial statements, business operations and prospects.

IDEAYA Announces Pricing of $300 Million Offering of Common Stock and Pre-Funded Warrants

SOUTH SAN FRANCISCO, Calif., June 8, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq:IDYA) today announced the pricing of an underwritten public offering of common...

Sony Semiconductor Solutions to Release X-ray CMOS Sensor with Industry’s Fastest(*1) Imaging and Low-Noise Performance for Inspection and Measurement Instrumentation

High-accuracy energy measurements and photon-level data acquisition on a single chipATSUGI, Japan, June 8, 2026 /PRNewswire/ -- Sony Semiconductor Solutions Corporation (Sony) today announced...

Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq

ARLINGTON, Mass., June 8, 2026 /PRNewswire/ -- Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX) ("Eloxx" and the "Company"), a clinical-stage biopharmaceutical company developing novel, small molecule...

Fireaway Achieves Type Approval and EU/UK Marine Equipment Certification for Stat-X® Condensed Aerosol Fire-Extinguishing Systems Following MSC.1/Circ.1270 Evaluation

Three certificates issued by Bureau Veritas support application in SOLAS-regulated marine environments across global, EU-flagged, and UK-flagged vessels.MINNETONKA, Minn., June 9, 2026 /PRNewswire/ --...

GraniteShares Announces Forward Splits

NEW YORK, June 08, 2026 (GLOBE NEWSWIRE) -- GraniteShares has announced it will execute forward shares split for the several funds (the “Funds”). The total market value of the shares outstanding will not be affected as a result of these splits.

Mama’s Creations Reports First Quarter Fiscal 2027 Financial Results

First Quarter Revenue Grows 50% to $52.8 Million; Net Income Increases 66% to $2.1 Million with Adjusted EBITDA Up 71% to $4.9 Million; Cash Position Grows to $24.4 Million

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsInc.

MUSSO E80 Muse Sees Strong U.S. Sales Following European Breakout and MUSE Design Award Win

Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor (NEXPOVIO®) Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026...

Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting